CALLICUTT JACK W Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$27,695.12
Insider Sells Quantity
8
Insider Sells Sum
$3M

Insider Activity of CALLICUTT JACK W

According to the SEC Form 4 filings, CALLICUTT JACK W, being in a position of

  1. Chief Financial Officer at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 96765 shares for $459,002,
    over all time since 2013-11-19, has bought 8874 shares for $27,695, and sold 553275 shares for $3.53M.

Biography of CALLICUTT JACK W

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $459,0028100

Comparison of Insiders on Amount of Buys and Sells

2026-01-06SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
20,354
0.0299%
$3.67$74,695-9.13%
2026-01-05SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
25,732
0.0401%
$3.90$100,298-19.07%
2026-01-02SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
13,914
0.0218%
$4.20$58,394-22.47%
2025-11-18SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
18,210
0.0284%
$6.22$113,321-47.9%
2025-11-17SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
2,323
0.0036%
$6.03$14,012-46.17%
2025-11-10SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
5,291
0.0096%
$6.03$31,884-36.25%
2025-11-05SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
200
0.0003%
$6.00$1,200-40.85%
2025-11-04SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
10,741
0.0175%
$6.07$65,198-41.09%
2025-11-03SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
2,510
0.0041%
$6.01$15,085-44.17%
2025-09-12SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
8,706
0.0163%
$6.44$56,054-35.85%
2024-12-23SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
40,000
0.064%
$0.89$35,492+157.27%
2022-11-17PurchaseGalectin Therapeutics Inc.
GALT
Chief Financial Officer
4,000
0.0065%
$1.32$5,280+22.79%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
Chief Financial Officer
2,354
0.005%
$4.28$10,075-23.33%
2018-06-20SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
97,267
0.2583%
$8.08$786,034-39.57%
2018-06-19SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
128,733
0.339%
$9.01$1.16M-46.15%
2018-06-12SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
9,294
0.0269%
$7.01$65,167-23.38%
2018-06-11SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
20,000
0.0558%
$6.38$127,500-18.9%
2018-06-08SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
100,000
0.2438%
$5.75$575,000-20.99%
2018-05-31SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
46,651
0.1201%
$5.00$233,255-3.74%
2018-04-04SaleGalectin Therapeutics Inc.
GALT
Chief Financial Officer
3,349
0.0092%
$5.00$16,745+3.16%
Total: 22
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.